A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
Overview
The purpose of this clinical research study is to determine if different dosage regimens of Sinemet® CR (Carbidopa/levodopa) are dose proportional
Full Title of Study: “An Open Label, Multiple-Dose Study ot Determine the Plasma Levodopa Profiles of Sinemet® CR (Carbidopa/Levodopa) at 4 Daily Dose Levels in Healthy Subjects”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
Interventions
- Drug: Sinemet® controlled release (Carbidopa/levodopa)
Participating in This Clinical Trial
Gender Eligibility: All
Minimum Age: 50 Years
Maximum Age: 75 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Bristol-Myers Squibb
- Overall Official(s)
- Bristol-Myers Squibb, Study Director, Bristol-Myers Squibb
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.